Applied Molecular Transport Inc.
NASDAQ: AMTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shawn M. Cross
- Employees
- 13
- Headquarters
- South San Francisco, United States
- IPO year
- 2020
- Market cap
- $11.0M
- Website
- https://www.appliedmt.com
Loading AMTI…
Loading profile data…Frequently asked questions about AMTI
What does Applied Molecular Transport Inc. (AMTI) do?
Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California. The firm is dedicated to discovering and advancing a pipeline of oral and respiratory biologic drug candidates, designed to address a variety of medical conditions including...
Where does AMTI trade?
Applied Molecular Transport Inc. (AMTI) trades on the NASDAQ Global Select.
What sector is AMTI in?
Applied Molecular Transport Inc. (AMTI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Applied Molecular Transport Inc.?
Shawn M. Cross is the chief executive officer of Applied Molecular Transport Inc. (AMTI).
Where is Applied Molecular Transport Inc. headquartered?
Applied Molecular Transport Inc. is headquartered in United States.
Does AMTI pay a dividend?
Applied Molecular Transport Inc. (AMTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMTI go public?
Applied Molecular Transport Inc. (AMTI) completed its initial public offering in 2020.